OKTA vs PROK · P/E 84, rev $1.57B vs rev $376.0K
Okta Inc (OKTA) versus ProKidney Corp. (PROK) — a side-by-side from cached financials, not a winner call.
Okta Inc (OKTA) is a software - infrastructure company listed on NASDAQ.
ProKidney Corp. (PROK) is a biotechnology company listed on US.
Latest reported OKTA revenue for 2026-07-31 was $1.57B. Net income was $190.0M. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
Latest reported PROK revenue for 2026-06-30 was $376.0K. Net income was -$48.5M. Revenue was up 66.4% from 2026-03-31 to 2026-06-30. PROK currently screens at market cap $543.7M.
OKTA currently screens at market cap $20.06B and trailing P/E 83.6. PROK currently screens at market cap $543.7M.
Not investment advice. Open the OKTA and PROK stock pages for the full models.
Not investment advice.